Advertisement

Ruxolitinib in the Treatment of Polycythemia Vera: Patient Selection and Special Considerations

In a meta-analysis, researchers concluded that ruxolitinib’s place in current practice should be directed toward disease-related symptoms relief after failure of standard treatment.

 Journal of Blood Medicine

click me